This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA Revokes Avastin Breast Cancer Approval After Disappointing Trials
The FDA rules Avastin should no longer be used to treat advanced breast cancer as studies show no extension of life or meaningful benefit, while risks include high blood pressure, bleeding, heart problems, and intestinal tears. Medicare will continue to cover Avastin, but insurers may refuse.
MENTIONED IN THIS ARTICLE
FDA
Washington
Food and Drug Administration
Margaret Hamburg
Avastin
Medicare
Brian Cook
Centers For Medicare & Medicaid Services
Sue Boyce
Chicago
Boyce
Genentech